Author Topic: Study shows LDN changes levels of inflammatory proteins in MS  (Read 105 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
Study shows LDN changes levels of inflammatory proteins in MS
« on: February 20, 2018, 02:35:13 pm »
LDN is seldom in the news but this is a report on a study showing some possible benefits from taking it for MS. From Multiple Sclerosis News Today, February 20, "Low-dose naltrexone changes levels of inflammatory proteins in MS, study shows":


https://multiplesclerosisnewstoday.com/2018/02/20/low-dose-naltrexone-changes-levels-inflammatory-proteins-in-ms/?utm_source=Multiple+Sclerosis&utm_campaign=3ad0d2cee2-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-3ad0d2cee2-71286581
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
93 Views
Last post March 17, 2019, 11:18:38 am
by agate
0 Replies
70 Views
Last post September 14, 2019, 06:56:51 pm
by agate
0 Replies
45 Views
Last post May 25, 2020, 06:42:18 am
by agate
0 Replies
39 Views
Last post March 05, 2021, 09:14:55 pm
by agate
0 Replies
62 Views
Last post June 21, 2021, 09:08:28 pm
by agate